CP and ovarian cancer: The down-regulation of non-coding RNA ceruloplasmin (NRCP), identified as a highly expressed lncRNA in ovarian cancer, can lead to increased apoptosis, decreased cell proliferation, and inhibition of glycolysis (Rupaimoole et al., 2015).